Overactive Bladder

Patients with osteoarthritis, but not immune-related arthritis, demonstrate increased odds for developing overactive bladder vs. those without, according to data spanning 15 years published in Science Reports.

The FDA has approved Axonics Inc’s fourth-generation R20 rechargeable sacral neuromodulation system for bladder and bowel dysfunction.

Researchers found a significant association between the menopausal status of women aged 45 to 54 years and overactive bladder, according to a study published in Menopause.

Patients with COVID-19 reported experiencing severe genitourinary symptoms during infection, and new or worsening overactive bladder symptoms after recovery, according to recent findings from two studies.

The novel muscarinic M3 receptor antagonist DA8010 significantly reduced urine frequency and urgency episodes compared with placebo in adults with overactive bladder, according to recent findings.

The FDA recently approved a new drug application for Gemtesa, a novel treatment for overactive bladder in adults, its manufacturer announced in a press release.

Results from the EMPOWUR extension study presented at the virtual International Continence Society Annual Meeting showed that vibegron, a beta-3 adrenergic agonist taken daily, could help treat patients with overactive bladder.

Considering urological diseases — prevalent in patients with CKD but frequently undiagnosed — during kidney disease assessments could help prevent the onset of CKD or slow the progression to ESKD, according to a published study.